SCHEMBL419148

SCHEMBL419148

COC(=O)c1cc(Cl)ccc1NC(=O)COc1cccc(-c2ccoc2)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.82
ALDH1A1 P00352 4/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TSHR P16473 1/20 0.48
MAPK10 P53779 1/20 0.48
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
LMNA P02545 1/20 0.47
THRB P10828 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL418786 0.90 SERPINE1 (1.00) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL29838682 0.90 SERPINE1 (1.00) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL417109 0.89 SERPINE1 (0.68) SERPINE1ALDH1A1TSHRMAPK10HSD17B10
SCHEMBL420208 0.89 SERPINE1 (0.65) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL419734 0.89 SERPINE1 (0.65) SERPINE1ALDH1A1TSHRMAPK10HSD17B10
SCHEMBL416730 0.88 SERPINE1 (0.66) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL418004 0.88 SERPINE1 (0.64) SERPINE1ALDH1A1TSHRMAPK10HSD17B10
SCHEMBL418116 0.87 SERPINE1 (0.62) SERPINE1ALDH1A1CYP1A2CYP2C19TSHR
SCHEMBL1015662 0.86 SERPINE1 (0.64) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL417150 0.85 SERPINE1 (0.60) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2607348-B1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE INC (JP) 2021-03-17 EP disclosed
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO LTD (JP) 2014-10-02 US disclosed
US-8785473-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2014-07-22 US disclosed
EP-2607348-A2 Plasminogen Activator Inhibitor-1 Inhibitor Renascience CO., LTD. (JP) 2013-06-26 EP disclosed
EP-2415755-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Renascience CO., LTD. (JP) 2012-02-08 EP disclosed
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE CO., LTD. (JP) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885ALDH1A1 1450/4885CYP1A2 2858/4885
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885ALDH1A1 1450/4885CYP1A2 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.